2540B |
LSD Trace Analysis, Blood |
2540SP |
LSD Trace Analysis, Serum/Plasma |
2540U |
LSD Trace Analysis, Urine |
2541B |
LSD Screen, Blood |
2584B |
Methylenedioxyamphetamine, Blood |
2584SP |
Methylenedioxyamphetamine, Serum/Plasma |
2584U |
Methylenedioxyamphetamine, Urine |
2585B |
Methylenedioxymethamphetamine and Metabolite, Blood |
2585SP |
Methylenedioxymethamphetamine and Metabolite, Serum/Plasma |
2585U |
Methylenedioxymethamphetamine and Metabolite, Urine |
4029B |
Psilocybin as Psilocin (Qualitative), Blood |
4029SP |
Psilocybin as Psilocin (Qualitative), Serum/Plasma |
4029U |
Psilocybin as Psilocin (Qualitative), Urine |
8104B |
Postmortem, Fire Death Screen, Blood (Forensic) |
8761B |
Phencyclidine, Blood |
8761FL |
Phencyclidine, Fluid |
8761ME |
Phencyclidine (Qualitative), Meconium |
8761SP |
Phencyclidine, Serum/Plasma |
8761TI |
Phencyclidine, Tissue |
8761U |
Phencyclidine, Urine |
8896OF |
Phencyclidine and Dextromethorphan (Qualitative), Oral Fluid (Saliva) |
8897OF |
Drugs of Abuse (7 Panel) (Qualitative), Oral Fluid (Saliva) |
8898OF |
Drugs of Abuse (6 Panel) (Qualitative), Oral Fluid (Saliva) |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |